Perez-Saez 2021

Current Status of Trial
Completed
Study Aim
Treatment Dementia
Study Design
RCT
Blinding
Single-blind
Intervention type
Non-pharmacological
Intervention
Reminiscence Therapy (RT)
Dosage and Duration
Intervention group (n = 74) received 26 individual RT sessions, twice a week for 13 weeks. Control group (n = 74) maintained their treatment as usual.
Absolute Number of Participants
148
Health Status/Diagnosis
Dementia
Primary outcomes
Cognition
Key Points
"The results showed a significant effect of the intervention on global cognition (Group X Time interaction F(1, 128) = 10.542, p = .001, etap 2 = .076), memory (F(1,128) = 9.881, p = .002, etap 2 = .072), and quality of life (F(1,128) = 0.181, p = .671, etap 2 = .001), with medium effect sizes. A small effect on executive function (F(1,127) = 11.118, p = .001, etap 2 = .080) was also found. No effects were found on depressive symptoms (F(1,128) = 0.181, p = .671, etap 2 = .001)." Perez-Saez 2021